Tag: NPPA
Prices of orthopedic knee implants set to be capped, hints govt
The National Pharmaceutical Pricing Authority (NPPA) has sought the views of all the concerned stakeholders on its preliminary analysis of orthopaedic implants that show huge trade margins for manufacturers and distributors.............
Govt says no shortage of essential drugs post introduction of GST
In all the cases of complaints on high prices, the concerned companies have been instructed to coordinate with the complainants and ensure supply of medicine to the complainants.........
We are watching: govt tells overcharging pharma firms
Demand notices of Rs 74.65 crore issued to pharmaceutical companies for launching drug formulations without prior price approval of NPPA..........
NPPA holds discussion with pharma bodies on GST implementation
National Pharmaceutical Pricing Authority (NPPA), has revealed that it met several pharma sector associations to decide the way forward for implementation of the GST.........
MedTech industry needs consensus, not confrontation!
The union government has gone tough on medical technology accessibility and affordability. While the stent prices have been capped, the responsibility to keep them available lies with companies....Read Editor's Take.....
MTaI demands categorization of stents, says not against price control
In its latest statement, the Medical Technology Association of India (MTaI) has conveyed to the government that while it isn't against the price control measures but believes that categorization of stents is necessary........
No complaint of inferior stents reported under CGHS, clarifies health ministry
The central government health scheme doesn't provide stents directly but the beneficiaries who avail the scheme are reimbursed the amount spent on medical stents.........
Mandatory for hospitals to issue patient’s bill with separate cost of...
State governments and state drug controllers have been advised to exercise powers under Para 30 of DPCO, 2013 to check artificial shortage of stent.........
Pharma firms deposit Rs 294.84 crores fine for overcharging patients
The money has been deposited against demand notices issued by the union government for overcharging patients for scheduled medicines...........
BioVoice eMag March 2017 Issue-10 Volume-1
BioVoice eMag March 2017 Issue-10 Volume-1:
This edition of BioVoice in its detailed cover story highlights the gains and pains of the budget 2017. The...